Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 337

1.

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder.

Greil W, Kleindienst N, Erazo N, Müller-Oerlinghausen B.

J Clin Psychopharmacol. 1998 Dec;18(6):455-60.

PMID:
9864077
[PubMed - indexed for MEDLINE]
2.

Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.

Kleindienst N, Greil W.

Neuropsychobiology. 2000;42 Suppl 1:2-10.

PMID:
11093063
[PubMed - indexed for MEDLINE]
3.

Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.

Greil W, Kleindienst N.

Int Clin Psychopharmacol. 1999 Sep;14(5):283-5.

PMID:
10529071
[PubMed - indexed for MEDLINE]
4.

The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.

Greil W, Kleindienst N.

Int Clin Psychopharmacol. 1999 Sep;14(5):277-81.

PMID:
10529070
[PubMed - indexed for MEDLINE]
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
6.

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM.

J Clin Psychiatry. 1997 Nov;58(11):470-8.

PMID:
9413412
[PubMed - indexed for MEDLINE]
7.

Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.

Baethge C, Gruschka P, Berghöfer A, Bauer M, Müller-Oerlinghausen B, Bschor T, Smolka MN.

J Affect Disord. 2004 Apr;79(1-3):43-50.

PMID:
15023479
[PubMed - indexed for MEDLINE]
8.

Predictors of response to mood stabilizers.

Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ.

J Clin Psychopharmacol. 1996 Apr;16(2 Suppl 1):24S-31S. Review.

PMID:
8707997
[PubMed - indexed for MEDLINE]
9.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
[PubMed - indexed for MEDLINE]
10.

Long-term outcome of lithium prophylaxis in bipolar disorder with mood-incongruent psychotic features: a prospective study.

Maj M, Pirozzi R, Bartoli L, Magliano L.

J Affect Disord. 2002 Sep;71(1-3):195-8.

PMID:
12167516
[PubMed - indexed for MEDLINE]
11.

Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder.

Kleindienst N, Greil W.

Psychol Med. 2002 Apr;32(3):493-501.

PMID:
11989994
[PubMed - indexed for MEDLINE]
12.

Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study.

Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T.

Eur Arch Psychiatry Clin Neurosci. 1997;247(1):42-50.

PMID:
9088805
[PubMed - indexed for MEDLINE]
13.

Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.

Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA; LitCar Group.

J Clin Psychiatry. 2003 Feb;64(2):144-51.

PMID:
12633122
[PubMed - indexed for MEDLINE]
14.

Evaluation of thyroid function in lithium-naive bipolar patients.

Valle J, Ayuso-Gutierrez JL, Abril A, Ayuso-Mateos JL.

Eur Psychiatry. 1999 Oct;14(6):341-5.

PMID:
10572366
[PubMed - indexed for MEDLINE]
15.

Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior.

Schou M.

Bipolar Disord. 1999 Sep;1(1):5-10.

PMID:
11256657
[PubMed - indexed for MEDLINE]
16.

Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study.

Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T.

J Affect Disord. 1997 Apr;43(2):151-61.

PMID:
9165384
[PubMed - indexed for MEDLINE]
17.

Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.

Denicoff KD, Smith-Jackson EE, Bryan AL, Ali SO, Post RM.

Am J Psychiatry. 1997 Oct;154(10):1456-8.

PMID:
9326833
[PubMed - indexed for MEDLINE]
18.

Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.

Mauri MC, Laini V, Scalvini ME, Volonteri LS, Ferrari MS, Panza G.

Eur Rev Med Pharmacol Sci. 1999 Mar-Apr;3(2):63-9.

PMID:
10827806
[PubMed - indexed for MEDLINE]
19.

The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.

Frye MA, Altshuler LL, Szuba MP, Finch NN, Mintz J.

J Clin Psychiatry. 1996 Jan;57(1):17-21.

PMID:
8543542
[PubMed - indexed for MEDLINE]
20.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.

J Clin Psychiatry. 2006 Jan;67(1):95-101.

PMID:
16426094
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk